Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.

Singh, Ajeet; Bharadwaj, Sujana J; Chirayath, Anju G; Ganguly, Satyaki

Singh, Ajeet; Bharadwaj, Sujana J; Chirayath, Anju G; Ganguly, Satyaki.

Afiliación

Singh A; Department of Dermatology, Venereology and Leprosy, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Bharadwaj SJ; Department of Dermatology, Venereology and Leprosy, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Chirayath AG; Department of Dermatology, Venereology and Leprosy, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Ganguly S; Department of Dermatology, Venereology and Leprosy, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

J Cosmet Dermatol ; 21(6): 2311-2314, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35348281

Asunto(s)

COVID-19; ChAdOx1 nCoV-19; Pénfigo; Adulto; COVID-19/prevención & control; ChAdOx1 nCoV-19/efectos adversos; Humanos; Masculino; Pénfigo/inducido químicamente; Pénfigo/tratamiento farmacológico; Vacunación/efectos adversos

Palabras clave

COVID-19 pandemic; ChAdOx1 nCoV-19; pemphigus vulgaris; recombinant vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Pénfigo / COVID-19 / ChAdOx1 nCoV-19 Límite: Adult / Humans / Male Idioma: En Revista: J Cosmet Dermatol Asunto de la revista: DERMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google